Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Current Assets (2016 - 2025)

SRx Health Solutions' Current Assets history spans 14 years, with the latest figure at $8.1 million for Q3 2025.

  • For Q3 2025, Current Assets fell 40.41% year-over-year to $8.1 million; the TTM value through Sep 2025 reached $8.1 million, down 40.41%, while the annual FY2025 figure was $8.1 million, N/A changed from the prior year.
  • Current Assets reached $8.1 million in Q3 2025 per SRXH's latest filing, down from $24.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $47.9 million in Q3 2021 to a low of $8.1 million in Q3 2025.
  • Average Current Assets over 5 years is $24.2 million, with a median of $19.9 million recorded in 2021.
  • Peak YoY movement for Current Assets: soared 223.08% in 2021, then crashed 50.53% in 2023.
  • A 5-year view of Current Assets shows it stood at $43.9 million in 2021, then plummeted by 37.33% to $27.5 million in 2022, then crashed by 41.03% to $16.2 million in 2023, then fell by 7.58% to $15.0 million in 2024, then plummeted by 45.83% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Current Assets are $8.1 million (Q3 2025), $24.5 million (Q2 2025), and $14.5 million (Q1 2025).